2026 State Pharmacy Lien Legislation Tracker: Which States Are Changing Rules

James Wong — Founder & Pharmacist, LienScripts | March 29, 2026 | 8 min read

At least nine states introduced or enacted legislation in 2026 that directly affects pharmacy lien rights in personal injury cases. This tracker covers every pending and enacted bill, from disclosure requirements to rate caps, so PI attorneys can stay ahead of changes that impact their clients' medication access and settlement math.

A wave of new state legislation in 2026 is reshaping pharmacy lien rights across the country, with at least nine states introducing bills that affect how pharmacies can place liens, what disclosures attorneys must make, and how lien balances factor into settlement recovery. PI attorneys who handle cases across state lines — or even within a single rapidly changing jurisdiction — need a current map of these developments to protect client outcomes.

• At least nine states introduced pharmacy lien or medical lien legislation in 2026, ranging from disclosure mandates to rate caps
• Florida, Georgia, and California continue leading aggressive lien reform; new entrants include Missouri, Ohio, and Pennsylvania
• Disclosure requirements are the most common new obligation, affecting how attorneys document lien-funded care in demand packages
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation that satisfies new disclosure mandates across all jurisdictions
• According to James Wong, PharmD, founder of LienScripts, "The 2026 legislative cycle is the most active we have seen for pharmacy lien regulation — attorneys need real-time awareness of what is changing in their state"

Florida: Continued Tightening After HB 837

Florida's 2023 tort reform (HB 837) already required disclosure of letters of protection at the outset of lien-based claims. In the 2026 session, two additional bills advanced:

SB 1042 would require pharmacy lien providers to submit itemized cost breakdowns to the defendant's insurer within 30 days of settlement demand. The bill passed the Senate Judiciary Committee in February 2026 and is pending floor vote as of March 2026.

HB 789 proposes capping pharmacy lien recovery at 200% of the Medicare Part D reimbursement rate for each dispensed medication. This bill remains in committee and faces significant opposition from pharmacy trade associations.

[!KEY] Florida attorneys should prepare for potential itemized disclosure requirements under SB 1042. Having a pharmacy lien partner that generates detailed, per-medication documentation eliminates compliance risk. The LienScripts platform produces this documentation automatically for every dispense.

Georgia: Expanding the SB 68 Framework

Georgia's SB 68 (2025) eliminated phantom damages by limiting medical expense claims to "reasonable value." The 2026 session introduced HB 1134, which would extend the reasonable-value framework specifically to pharmacy liens — requiring that lien amounts be supported by documentation of the medication's average wholesale price (AWP) and the dispensing pharmacy's usual and customary charges.

This is a significant shift. Previously, Georgia pharmacy liens operated under the general lien statute without medication-specific documentation requirements. HB 1134 would make Georgia the first state to require AWP-based justification for pharmacy lien balances.

California: Ballot Initiative and Legislative Response

Beyond the Uber-backed ballot initiative (Initiative #25-0022) that would cap medical expense recovery at Medicare rates for auto accident cases, the California legislature introduced AB 2891 in January 2026. This bill would create a state registry of lien-based medical providers, including pharmacies, and require annual certification that the provider's billing practices comply with Business and Professions Code requirements.

The registry requirement is designed as a consumer protection measure but would impose new administrative obligations on pharmacy lien programs operating in California.

Missouri: New Lien Disclosure Statute

HB 455 (introduced January 2026) would require that any medical provider placing a lien on a PI settlement provide the patient with a written disclosure of the lien terms, including the maximum amount that could be claimed, within 10 business days of the first service rendered. This applies explicitly to pharmacy liens.

Missouri currently has no pharmacy-specific lien disclosure requirement. If enacted, HB 455 would make Missouri the 14th state with a formal lien disclosure obligation.

[!TIP] When enrolling patients in a pharmacy lien program in Missouri (and any state with pending disclosure legislation), ensure the enrollment documentation includes the maximum potential lien amount and the patient's acknowledgment. The LienScripts enrollment process includes this disclosure by default.

Ohio: Medical Lien Registration Bill

SB 312 would create a centralized medical lien registry maintained by the Ohio Secretary of State. All medical liens, including pharmacy liens, would need to be registered within 60 days of the first service to maintain perfection priority. Unregistered liens would be subordinate to all registered liens in settlement distribution.

This mirrors the UCC filing system for security interests and would fundamentally change how pharmacy liens are perfected in Ohio.

Pennsylvania: Rate Transparency Requirement

HB 1567 proposes requiring that any medical provider billing on a lien basis in a PI case disclose the difference between the lien amount and the amount that would have been billed to the patient's health insurer (if any) for the same services. The bill does not cap lien amounts but aims to create a transparency mechanism.

Pennsylvania PI attorneys should note that this bill, if enacted, would require access to the patient's insurance formulary pricing — information that pharmacy lien providers would need to supply or help document.

Texas: Expanding Existing Lien Protections

Texas already has one of the most developed medical lien frameworks (Texas Property Code Chapter 55). SB 891 (2026) would expand the definition of "health care provider" in the lien statute to explicitly include pharmacies and pharmacy benefit managers, closing an ambiguity that some insurers have exploited to challenge pharmacy lien validity.

Minnesota: Lien Notification Requirements

HF 2234 would require lien-holding medical providers, including pharmacies, to notify the defendant's liability insurer of the lien within 30 days of placement. Currently, Minnesota law requires only that the lien be filed with the county recorder. The bill adds an active notification duty that, if missed, could affect lien priority.

Colorado: Medical Expense Transparency Act

SB 26-089 would require all medical providers billing on a lien basis to provide patients with a "plain language summary" of lien terms at enrollment and a quarterly statement of the running balance. The bill includes pharmacy services within its scope and would take effect January 2027 if enacted.

[!KEY] The trend across all nine states is toward greater disclosure, transparency, and documentation requirements for lien-based care. Attorneys who partner with a pharmacy lien provider that already generates comprehensive, per-medication documentation are positioned to comply with these emerging requirements without changing their workflow.

What This Means for Multi-State PI Practices

Attorneys handling cases in multiple jurisdictions face the most complex compliance landscape. A single firm with cases in Florida, Georgia, and California could be subject to three different disclosure frameworks, two different rate-justification standards, and a pending ballot initiative — all in 2026.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The LienScripts platform is built to generate jurisdiction-specific documentation. Whether a state requires AWP-based pricing justification, itemized cost breakdowns, or patient-facing disclosure statements, the platform produces the right documentation for the right state automatically."

Tracking Resources

• National Conference of State Legislatures (NCSL): Maintains a database of medical lien legislation searchable by state and session year
• American Tort Reform Association (ATRA): Publishes quarterly legislative updates covering lien-related bills
• Consumer Attorneys of California (CAOC): Leads opposition to Initiative #25-0022 and publishes detailed legislative analysis for California-specific developments

Related Resources

• California's 2026 Ballot Initiative
• Florida HB 837 and Pharmacy Liens
• Georgia SB 68 and Phantom Damages
• What Is a Pharmacy Lien?